Sharp, a provider of global contract packaging clinical supply services, has launched a new Inventory Management System (IMS) to support clinical trial sponsors in managing inventory and supplies.
The new system—named Clinventory—has been designed to provide full visibility of stock levels at investigator sites and tracking product through the supply chain. It ensures that sponsors have a comprehensive, real-time view of their trial.
Using the Clinventory IMS will also create efficiencies for trial sponsors by improving the drug management process by leveraging automation to increase reliability, while reducing the costs associated with manual processes.
“At Sharp, we are always exploring ways to support our clients’ efforts to create more efficiency and lower the cost of their clinical trials,” said Sascha Sonnenberg, global head of business development, Sharp Clinical. “Clinventory has been designed specifically with those smaller-volume, early stage or open label clinical trials in mind, where a larger, more expensive inventory system might offer an array of functionality that is surplus to needs.”
Key features of the Clinventory IMS include:
• On-demand study supply information
• Eliminates the need for manual processes for dispatches and returns
• Customizable automatic resupply, which can be updated as the study enrolment increases or decreases
• Temperature excursion tracking with supply release and approval
• Manual shipment requests for emergency situations.
The system complements Sharp’s Clinteract Interactive Response Technology (IRT) solution, which delivers all the features of Clinventory IMS plus subject enrolment and trial randomization functionality.
The availability of Clinventory IMS means the company’s clients now have a choice of trial management solutions appropriate to the scale of their trial.
Several of Sharp’s clinical services experts will be presenting a webinar on ‘Choosing the Right Clinical Trial Solution for Distribution and Supply Optimization’ which will explore the difference between IRT and IMS. You can register for the event, which takes places on September 8, 2020, here.
The new system—named Clinventory—has been designed to provide full visibility of stock levels at investigator sites and tracking product through the supply chain. It ensures that sponsors have a comprehensive, real-time view of their trial.
Using the Clinventory IMS will also create efficiencies for trial sponsors by improving the drug management process by leveraging automation to increase reliability, while reducing the costs associated with manual processes.
“At Sharp, we are always exploring ways to support our clients’ efforts to create more efficiency and lower the cost of their clinical trials,” said Sascha Sonnenberg, global head of business development, Sharp Clinical. “Clinventory has been designed specifically with those smaller-volume, early stage or open label clinical trials in mind, where a larger, more expensive inventory system might offer an array of functionality that is surplus to needs.”
Key features of the Clinventory IMS include:
• On-demand study supply information
• Eliminates the need for manual processes for dispatches and returns
• Customizable automatic resupply, which can be updated as the study enrolment increases or decreases
• Temperature excursion tracking with supply release and approval
• Manual shipment requests for emergency situations.
The system complements Sharp’s Clinteract Interactive Response Technology (IRT) solution, which delivers all the features of Clinventory IMS plus subject enrolment and trial randomization functionality.
The availability of Clinventory IMS means the company’s clients now have a choice of trial management solutions appropriate to the scale of their trial.
Several of Sharp’s clinical services experts will be presenting a webinar on ‘Choosing the Right Clinical Trial Solution for Distribution and Supply Optimization’ which will explore the difference between IRT and IMS. You can register for the event, which takes places on September 8, 2020, here.
Recent Comments